This protocol is judged by an institutional evaluation board, an unbiased group that reviews any clinical trials involving people. If a research involves a Timetable I drug, after the board approves the protocol as moral, the researchers must submit an application for an investigational new drug (IND) quantity from your FDA.Buyers reported little